PELLEGRINI, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.221
NA - Nord America 1.556
EU - Europa 467
SA - Sud America 397
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 4.693
Nazione #
US - Stati Uniti d'America 1.498
SG - Singapore 949
CN - Cina 442
BR - Brasile 324
HK - Hong Kong 289
VN - Vietnam 206
FR - Francia 153
IT - Italia 136
KR - Corea 69
BD - Bangladesh 55
JP - Giappone 49
IN - India 46
GB - Regno Unito 33
AR - Argentina 28
DE - Germania 27
CA - Canada 25
NL - Olanda 25
ID - Indonesia 22
FI - Finlandia 18
IQ - Iraq 16
EC - Ecuador 14
MX - Messico 14
IL - Israele 13
SE - Svezia 12
ES - Italia 10
TR - Turchia 9
UA - Ucraina 9
MA - Marocco 8
PE - Perù 8
PK - Pakistan 8
ZA - Sudafrica 8
KE - Kenya 7
VE - Venezuela 7
AU - Australia 6
PL - Polonia 6
SA - Arabia Saudita 6
CL - Cile 5
IE - Irlanda 5
JM - Giamaica 5
MY - Malesia 5
RU - Federazione Russa 5
CO - Colombia 4
ET - Etiopia 4
HR - Croazia 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
AL - Albania 3
AT - Austria 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
KG - Kirghizistan 3
LT - Lituania 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HN - Honduras 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
SV - El Salvador 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
Totale 4.684
Città #
Santa Clara 766
Singapore 555
Hong Kong 283
Hefei 170
San Jose 148
Beijing 107
Lauterbourg 106
Ashburn 93
Ho Chi Minh City 73
Los Angeles 64
Seoul 64
Hanoi 48
Tokyo 35
New York 34
São Paulo 33
Buffalo 24
Dallas 24
Helsinki 15
Da Nang 13
Rome 11
Minamishinagawa 10
Orem 10
Rio de Janeiro 10
Stockholm 10
Montreal 9
Baghdad 8
Belo Horizonte 8
Bengaluru 8
Dhaka 8
Atlanta 7
Campinas 7
Chennai 7
Frankfurt am Main 7
Mumbai 7
Brooklyn 6
Chicago 6
Denver 6
Düsseldorf 6
Guayaquil 6
Johannesburg 6
Nairobi 6
Phoenix 6
Thái Bình 6
Toronto 6
Biên Hòa 5
Brasília 5
Charlotte 5
Dublin 5
Haiphong 5
Houston 5
Kuala Lumpur 5
Milan 5
Nuremberg 5
Porto Alegre 5
Queens 5
Quito 5
Riyadh 5
Shanghai 5
Warsaw 5
Baltimore 4
Canyon Country 4
Casablanca 4
Contagem 4
Council Bluffs 4
Curitiba 4
Guangzhou 4
Jakarta 4
London 4
Marigliano 4
Miami 4
Montevideo 4
Newark 4
Portsmouth 4
Seattle 4
Thái Nguyên 4
Addis Ababa 3
Amman 3
Araruama 3
Florence 3
Fort Worth 3
Hangzhou 3
Hải Dương 3
Kingston 3
Kyiv 3
Lima 3
Manchester 3
Mexico City 3
Nanjing 3
Nha Trang 3
Pescara 3
Piscataway 3
Ribeirão Preto 3
Sydney 3
São Carlos 3
São José dos Campos 3
Tashkent 3
The Bronx 3
Tirana 3
Turin 3
Wuhan 3
Totale 3.056
Nome #
Classification of cancer stage using the immune system. 98
Are Immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? 93
Analisi longitudinale delle sottopopolazioni T-linfocitarie nella Sclerosi Multipla. 89
Immunological mechanisms in the establishment and progression of colon cancer. 72
Day of Immunology 2015 69
Cytokines in colon cancer patients. 65
The definition of a panel of clinical biomarkers of homeostasis: a new promising tool for prevention and treatment of chronic-degenerative 65
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance. 65
CD30 antigen: not a physiological marker for TH2 cells but animportant costimulator molecule in the regulation of the balance between TH1/TH2 response 62
Redox, immune and genetic biomarker system for personalized treatments in colorectal cancer 60
CD30 Molecule, The Immune System and Multiple Sclerosis. 60
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy 60
Farmaci neurolettici e produzione di linfochine "in vitro" in pazienti schizofrenici. 58
Tumor stage and serum levels of sIL-2R in colon cancer patients 55
Violent Behaviours among Adolescents and Young Adults: Association with Psychoactive Substance Use and Parenting Styles. 54
IDENTIFICATION OF BIOMARKERS FOR TAILORED TREATMENT OF COLORECTAL CANCER: RELATIONSHIP BETWEEN CYTOKINES, KIR AND CD16A GENE POLYMORPHISMS 54
The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates. 52
Cytokines in colon cancer patients: Disease markers in cancer therapy. Il-2 receptor 51
Attività linfocitaria nella schizofrenia: uno studio controllato 50
COLORECTAL CANCER: NEW BIOMARKERS SYSTEM IN PREVENTION AND TREATMENT 50
Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer. 49
Immunological directives for biotherapy improvement in the treatment of colorectal cancer. 48
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy 48
Medical research news in the understanding, diagnosis, treatment, cure or prevention of cancer disease: "ARE IMMUNOLOGICAL MECHANISMS INVOLVED IN COLON CANCER AND ARE THEY POSSIBLE MARKERS FOR BIOTHERAPY IMPROVEMENT?" 48
IL-8 involvement in immune disregulation of cancer patients 48
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age 47
Immunological pathways in diagnosis, treatment, cure and prevention of human disease: "Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer" 47
Livelli serici di IL-2, sIL-2R, IL-6 and TNF nella schizofrenia: uno studio controllato 46
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy 46
Medical research news in the understanding, diagnosis, treatment, cure or prevention of human disease: "Ageing gender-specific targets/biomarkers for the identification of drugs with specific gender-related action and more appropriate therapeutic strategies." 45
A gender-related action of IFNß-therapy was found in multiple sclerosis. 45
Modificazioni genetiche ed aggressività del cancro del colon 45
Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients. 43
Modificazioni indotte dalla L-Enkefalina sull'attivita' di singoli neuroni di mollusco 42
Prognostic indices for the early classification of colon cancer stage 42
IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer 42
Prognostic indices for the early classification of colon cancer stage. 41
Soluble IL-2 Receptor and proliferative responses to IL-2+anti-CD3 monoclonal antibody in colon cancer 41
Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer 41
The immunological implications of gene alterations in the progression of colorectal cancer: indications for prognosis, treatment and tumor understanding. 40
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patients 40
The study of patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. 40
Immunological mechanisms in the establishment and progression of colon caner 40
Bcl-2 and drugs used in the treatment of cancer: New strategies of biotherapy which should not be underestimated. 39
Hypothesis of the variable clinical response to immunotherapeutic treatments in colon cancer patients 38
Colon cancer: sIL-2R and correlated mechanisms 38
Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and 38
Marcatori di linfociti nell'anziano in emodialisi periodica 38
Cancer establishment and progression 37
Immunological implications of alterations in the c-ki-ras and p53 gene in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding 37
Production of cytokines in schizophrenic patients: correlation with pharmacological treatment 36
Bone marrow transplantation in siblings:correlation of MLC, serological and DNA typing 36
L'ipotesi autoimmunitaria della schizofrenia. Recettore solubile dell'Interleuchina 2 e Tumor Necrosis Factor. 36
IFNbeta therapy dose makes functional efficiency differences in Multiple Sclerosis patienst 36
Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network. 36
HLA antigens in multiple sclerosis 35
IL-6 and NK activity in colorectal cancer. 35
MLC test and/or DNA typing in Bone Marrow transplantation 35
Trapianto di midollo osseo da donatore non consanguineo: compatibilità HLA 35
Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression 34
DETECTION OF CIRCULATING ICAM-1 AND SOLUBLE IL-2 RECEPTOR IN SERUM OF COLORECTAL CANCER PATIENTS 34
Serum factor may interact with T8+ cells during the clinical course of multiple sclerosis. 34
Colon cancer: hypotesis of progression mechanism 34
The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back. 34
Immune disregulation in colon cancer 34
Ras family oncogenes in oral cancer 34
IFNbeta-1a treatment and reestablishment of TH1 regulation in MS patients: dose effects. 33
Analisi del DNA heteroduplex per il locus HLA-DP nel trapianto di midollo osseo. 33
Monitoraggio serico di sIL-2R nel trapianto renale. 33
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions 33
Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules 32
Cytokines in Schizophrenia 32
Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. 32
Ottimizzazione della ricerca di anticorpi anti-HLA su panel cellulare 32
HLA expression on tumor cells and serum levels of soluble IL-2 receptor in colorectal cancer 32
Role of HLA-restricted T cells in colorectal cancer 32
Blockade of N Methyl D-Aspartate receptor prevents Hypoxic Neuronal dath and Cytokine release. 32
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer 32
Relationships between the activity of MMPI/TIMPI enzymes and the TH1/TH2 cytokine network 32
Detection of circulating ICAM-1 and soluble IL-2 receptor in serum of colon cancer patients 32
In vitro evaluation of the immunological response in colon cancer patients: effects of IL-2, IL-4 and anti-CD3MoAb 31
Serum levels of IL-2, soluble IL-2R, TNF, Il-6 in schizophrenic patients: a controlled study 31
The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments 31
Identification of a serum factor interacting with a subset of OKT8+ cells in M.S. 31
Functional and phenotipic analysys of lymphocytes from tumor-draining lymph nodes in colon neoplasms 30
T-Lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity. 30
HLA-DR6 antigen in Schizophrenia 30
Cultured hyppocampal neurons may secrete a compound inhibiting PHA-induced lymph cells proliferation 30
Presence in multiple sclerosis of serum factors wich modulate "in vitro" reactivity to T8 moAb. 29
TNF, IL-6 and soluble IL-2 Receptor in colorectal cancer: comparison of "in vitro" and "in vivo" findings 29
The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer 29
CD30: an important costimulator molecule in the regulation of the balance between TH1/TH2 response 28
Prognostic Significance of immunological evaluation in colorectal cancer. 28
Negative association of the HLA-DR 6 antigen in Schizophrenia. 28
Inibizione dei neuroni centrali sulla risposta proliferativa delle cellule mononucleate di sangue periferico 28
Serum levels of soluble IL-2 receptor in cancer patients. 28
Disease markers in cancer patients: IL-2 receptor 27
Carcinoembryonic antigen and soluble interleukin-2 receptor in colon cancer 27
Loci Ia-LIKE e risposta alle malattie 27
Cytokine contribution to the repair processess and homeostasis recovery following anoxic insult: a possible IFN regulating role in IL1 neurotoxic action in physiological or damaged CNS 27
Totale 4.150
Categoria #
all - tutte 16.084
article - articoli 11.096
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.109
Totale 28.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 0 0 0 0 2 2 7 8
2024/20251.939 4 20 118 74 650 115 25 42 41 90 396 364
2025/20262.614 123 231 247 374 415 184 380 139 168 183 116 54
2026/2027121 115 6 0 0 0 0 0 0 0 0 0 0
Totale 4.693